lobbying_activities: 1623844

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1623844	712ed119-5837-4efb-9ddd-4e63749f4837	Q4	EMPIRE CONSULTING GROUP	400703105	PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA	2014	fourth_quarter	PHA	Issues relating to the Medicare Prescription Drug Act; 340B Drug Pricing Program and drug pricing generally; health disparities in diverse communities.	HOUSE OF REPRESENTATIVES	40000		0	0	2015-01-16T10:15:21.113000-05:00